Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of extended treatment
with FK228 in patients with metastatic renal cell carcinoma or hormone refractory prostate
cancer who have at least demonstrated stable disease on prior Fujisawa sponsored FK228
clinical trials.